Today’s podcast guest, Prof. Elfriede Noessner will walk us through the complexities of the immune system, explain how it is being influenced to cure cancer and what role tissue image analysis plays in immuno-oncology.
Prestigious International Annual Awards Program Recognises Standout Digital Health & Medical Technology Products and Companies
Aiosyn, a software company that develops AI-powered pathology software, has announced the integration of its AI-powered automated quality control (QC) algorithm in the Sectra Amplifier Marketplace. Through the Sectra platform, pathology laboratories can now easily access and integrate AiosynQC into their workflow.
In a recent proof-of-concept study, Trinity College Dublin researchers at Coombe Women’s and Infants University Hospital and St. James’s Hospital, Dublin, Ireland, developed and tested a low-cost CTC isolation and characterization pipeline based on digital pathology methods.1
Aiforia Technologies Plc, Company release, 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development.
A survey of members of the UK Liver Pathology Group (UKLPG) was conducted, comprising consultant histopathologists from across the UK who report liver specimens and participate in the UK National Liver Pathology External Quality Assurance scheme. The aim of this study was to understand attitudes and priorities of liver pathologists towards digital pathology and artificial intelligence (AI).
Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform company focused on cancer biomarkers announced an agreement to provide a fully interoperable solution between Indica Labs' HALO AP® image management software platform and Lunit's suite of AI pathology products. The combined solution is already in use at Guardant Health, a leading precision oncology company
Cloud-based digital pathology platform helps CRO deliver more informed preclinical studies
At the time of initial melanoma diagnosis, the analysis of spatial biology reveals that B cell follicles in secondary lymphoid structures may have a role in regulating anti-tumor responses.
Philips and Saint-Joseph Hospital & Marie-Lannelongue Hospital, one of France’s leading centers of excellence in cancer care, have announced the first steps in a partnership to fully integrate digital pathology into the Saint-Joseph and Marie Lannelongue hospitals’ enterprise imaging workflow, allowing care teams access to comprehensive diagnostic information at the anatomical, cellular, and molecular level. As a result, the hospitals’ multidisciplinary tumor boards will be able to better guide personalized care pathway selection for cancer patients through integration across digital pathology and radiology workflows.
